- Target
- CD225
- Reactivity
- Human
- Application
- WB,IHC,IF,IP,ELISA
- MW(Calculated)
- 14kD
- MW(Observed)
- 17kD
- Host Species
- Rabbit
- Isotype
- IgG,Kappa
- Conjugate/Modification
- Unmodified
- Modification site
- --
- Recommended Dilution Ratio
- IHC 1:200-1:1000;WB 1:2000-1:10000;IF 1:200-1:1000;ELISA 1:5000-1:20000;IP 1:50-1:200;
- Form
- PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
- Source
- --
- Purification
- Protein A
- Purity
- --
- storageCondition
- -15°C to -25°C/1 year(Do not lower than -25°C)
- Concentration
- --
- Clonality
- Monoclonal
- Clone No.
- PT1789R
- Immunogen
- --
- Sequence
- --
- Specificity
- Endogenous
- Gene Name
- IFITM1
- Protein Name
- Interferon-induced transmembrane protein 1
- Other Name
- IFITM1;CD225;IFI17;Interferon-induced transmembrane protein 1;Dispanin subfamily A member 2a;DSPA2a;Interferon-induced protein 17;Interferon-inducible protein 9-27;Leu-13 antigen;CD225
- Organism-1
- Human
- Gene ID-1
- 8519
- SwissProt-1
- P13164
- Organism-2
- Mouse
- Gene ID-2
- 68713
- SwissProt-2
- Q9D103
- Organism-3
- --
- Gene ID-3
- --
- SwissProt-3
- --
- Organism-4
- --
- gene ID-4
- --
- SwissProt-4
- --
- Cellular Localization
- Bone (at protein level). Levels greatly elevated in colon cancer, cervical cancer, esophageal cancer and ovarian cancer. Expressed in glioma cell lines.